Financial reports
Current reports
6-K
Invitation to the Annual General Meeting 2024
8 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Current report (foreign)
22 Mar 24
6-K
BioNTech Announces Fourth Quarter and Full Year 2023
20 Mar 24
6-K
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
20 Mar 24
6-K
BioNTech to Present Clinical Data Updates For Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
11 Mar 24
6-K
BioNTech Announces Planned Retirement of Sean Marett
7 Mar 24
6-K
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
8 Feb 24
6-K
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
31 Jan 24
6-K
Current report (foreign)
22 Jan 24
Registration and prospectus
S-8
Registration of securities for employees
15 Feb 24
S-8
Registration of securities for employees
13 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Feb 23
D
$150M in equity, sold $150M, 1 investor
14 Apr 22
S-8
Registration of securities for employees
18 Feb 21
F-3ASR
Automatic shelf registration (foreign)
10 Nov 20
D
$250M in equity / debt, sold $250M, 2 investors
17 Sep 20
424B3
Prospectus supplement
27 Aug 20
424B3
Prospectus supplement
21 Aug 20
424B3
Prospectus supplement
12 Aug 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
27 Jul 20
EFFECT
Notice of effectiveness
23 Jul 20
EFFECT
Notice of effectiveness
3 Apr 20
CORRESP
Correspondence with SEC
31 Mar 20
UPLOAD
Letter from SEC
25 Feb 20
EFFECT
Notice of effectiveness
6 Feb 20
CORRESP
Correspondence with SEC
3 Feb 20
CORRESP
Correspondence with SEC
3 Feb 20
SEC STAFF
SEC staff action: Order
29 Jan 20
SEC STAFF
SEC staff action: Order
29 Jan 20
Ownership
144
Notice of proposed sale of securities
28 Feb 24
SC 13D
Autolus Therapeutics plc
21 Feb 24
SC 13G/A
Medine GmbH
14 Feb 24
SC 13G/A
ATHOS KG
7 Feb 24
144
Notice of proposed sale of securities
4 Jan 24
144/A
Notice of proposed sale of securities (amended)
10 Oct 23
144
Notice of proposed sale of securities
29 Sep 23
144
Notice of proposed sale of securities
29 Sep 23
144/A
Notice of proposed sale of securities (amended)
14 Aug 23
144
Notice of proposed sale of securities
29 Jun 23